Albert Labs

Fully-integrated biopharma company Albert Labs International Corp.’s international patent application covering IP around a novel manufacturing technology for the production and scaling of fungi biomass yields including psilocybin has received preliminary acceptance by the World International...

This article by Freddie Earlam was originally published on Microdose and appears here with permission. If the industry-defining research already conducted at UK centers such as Imperial College, King’s college or even Exeter University’s recent Ketamine Research...

Albert Labs, a British-Columbia based biotech company, announced Thursday that it closed its private placement and that its shares will begin trading on the Canadian Securities Exchange (CSE). Albert Labs will trade under the ticker symbol “ABRT.”  “The listing is the first...

Psychedelic-based medicines company Albert Labs is going public. On Monday, management said it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange (CSE). The stock is expected to start trading under the ticker "ABRT" in early 2022,...